Hyperglycemia, for example, can increase the expression of NOX1 in human aortic ECs, while inhibition of NOX1 in diabetic apolipoprotein-E (ApoE) deficient mice reduces atherosclerosis development (155). This evidence concerns the gene NOX1 and atherosclerosis.